Maternal <i>β</i>-Hemolytic Streptococcal Pharyngeal Exposure and Colonization in Pregnancy

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td align="left"> </td><td align="center">   1st  trimester</td><td align="center">  2nd trimester </td><td align="center">  3rd trimester </td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td align="left">ASO</td><td align="center">164</td><td align="center">157</td><td align="center">156</td></tr><tr><td align="left">Anti-DNase B<sup>a</sup></td><td align="center">170</td><td align="center">170</td><td align="center">170</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><sup>a</sup>Just considering anti-DNase B titers measured by Wampole kit.<br/>ULN: upper limit of normal; ASO: antistreptolysin O.<br/></td></tr></table>

ULN values of the ASO and anti-DNase titers in pregnant women.

Infectious Diseases in Obstetrics and Gynecology

tab3

Table 3

Table 3: Maternal <i>β</i>-Hemolytic Streptococcal Pharyngeal Exposure and Colonization in Pregnancy 

Infectious Diseases in Obstetrics and Gynecology

Maternal β-Hemolytic Streptococcal Pharyngeal Exposure and Colonization in Pregnancy

Table 3